Search Results

1 - 5 of 5 items :

  • Quality of life x
  • Endocrinology, Diabetology x
  • Basic Medical Science x
Clear All
Possible association of ghrelin/obestatin balance with cardiometabolic risk in obese subjects with Helicobacter pylori

on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease. Hepatogastroenterology 49, 1298–1302, 2002. Garrow JS, Webster J. Quetelet’s index (W/H2) as a measure of fatness. Int J Obes 9, 147–153, 1985. Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and lowgrade inflammation. South Med J 103, 190–196, 2010. Gokcel A, Gumurdulu Y, Kayaselcuk F, Serin E, Ozer B, Ozsahin AK, Guvener N. Helicobacter pylori has no effect on plasma ghrelin

Open access
Salivary adiponectin concentration in healthy adult males in relation to anthropometric measures and fat distribution

Impedance Analysis Method in Korean Subjects. Nutrients 7, 10513-10524, 2015. Lee EH, Lee YW, Moon SH. A Structural Equation Model Linking Health Literacy to Self-effi cacy, Self-care Activities, and Health related Quality of Life in Patients with Type 2 Diabetes. Asian Nurs Res (Korean Soc Nurs Sci), 10, 82-7, 2016. Liu M, Liu F. Transcriptional and post-translational regulation of adiponectin. Biochem J 425, 41-52, 2009. McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral

Open access
Co-exposure to endocrine disruptors: effect of bisphenol A and soy extract on glucose homeostasis and related metabolic disorders in male mice

cancer cells by phytoestrogens and endocrine disruptors. Curr Med Chem 21, 1129–1145, 2014. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114, 106–112, 2006. Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 30, 79–91, 2011. Angle BM, Do RP, Ponzi D, Stahlhut RW, Drury BE, Nagel SC, Welshons WV

Open access
A short review of primary aldosteronism in a question and answer fashion

References AAES, T.A.A.o.E.S. Primary hyperaldosteronism (Conn’s syndrome or aldosterone-producing adrenal tumor). Patient Education. 2016. Agharazii M, Douville P, Grose JH, Lebel M. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37, 1440-1443, 2001. Ahmed AH, Gordon RD, Sukor N, Pimenta E, Stowasser M. Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our

Open access
Pheochromocytoma

clinicians. Curr Hypertens Rep 16, 442, 2014. Pick L. Das Ganglioma embryonale sympathicum (Sympathoma embryonale). Berl Klin Wschnschr 49, 16–22, 1912. Pillai S, Gopalan V, Smith RA, Lam AK. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era. Crit Rev Oncol Hematol 100, 190–208, 2016. Plesoianu CE, Andriescu G, Salaru D, Georgescu CA. The relationship between biochemical variables and the quality of life in patients with chronic heart failure. Rev Chim (Bucharest), 68, 2452–2458, 2017. Plouin PF

Open access